RETRACTED: International experience in drug names assessment: European Medicines Agency

RETRACTED ARTICLEThe present article considers the experience of a unitary expert and control authority regulating the circulation of medicines in the European Union (EU) – the European Medicines Agency. It also describes the main contents of the current EU regulatory documentation on the newly form...

Full description

Saved in:

Bibliographic Details
Published in:	Регуляторные исследования и экспертиза лекарственных средств no. 2; pp. 38 - 42
Main Authors:	A. N. Mironov, I. V. Sakaeva, V. V. Dudchenko, L. V. Korneeva, A. N. Yavorsky
Format:	Journal Article
Language:	Russian
Published:	Federal State Budgetary Institution ‘Scientific Centre for Expert Evaluation of Medicinal Products’ of the Ministry of Health of the Russian Federation (FSBI ‘SCEEMP’) 01-12-2018
Subjects:	assessment drug drug name the european medicines agency
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Description
Summary:	RETRACTED ARTICLEThe present article considers the experience of a unitary expert and control authority regulating the circulation of medicines in the European Union (EU) – the European Medicines Agency. It also describes the main contents of the current EU regulatory documentation on the newly formed drug names eligibility criteria. These criteria are directed to protect consumer's rights and allow to prevent adverse effects on human health and life caused by the marketing authorization of new drugs, which names are identical or confusingly similar with the names of previously authorized products, but different in composition and effects.
ISSN:	3034-3062 3034-3453